Pierre Julien Moro

CYP2C19*2 and *17 Alleles Have a Significant Impact on Platelet Response and Bleeding Risk in Patients Treated With Prasugrel After Acute Coronary Syndrome

Thomas Cuisset, Marie Loosveld, Pierre‐Emmanuel Morange et al. · JACC: Cardiovascular Interventions · 2012 · 102 citations

Thrombosis, Cardiovascular Disease, Platelet Response +12

Effect of CYP2C19*2 and *17 Genetic Variants on Platelet Response to Clopidogrel and Prasugrel Maintenance Dose and Relation to Bleeding Complications

Charlotte Grosdidier, Jacques Quilici, Marie Loosveld et al. · The American Journal of Cardiology · 2013 · 69 citations

Thrombopoiesis, Thrombosis, Bleeding Complications +12

Epicardial Fat Volume Is Associated With Coronary Microvascular Response in Healthy Subjects: A Pilot Study

Bénédicte Gaborit, Frank Kober, Alexis Jacquier et al. · Obesity · 2011 · 32 citations · Full text

Platelet reactivity in diabetic patients undergoing coronary stenting for acute coronary syndrome treated with clopidogrel loading dose followed by prasugrel maintenance therapy

Thomas Cuisset, Bénédicte Gaborit, Noémie Dubois et al. · International Journal of Cardiology · 2012 · 28 citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +12

Comparison between initial and chronic response to clopidogrel therapy after coronary stenting for acute coronary syndrome and influence on clinical outcomes

Thomas Cuisset, Jacques Quilici, Marie Loosveld et al. · American Heart Journal · 2012 · 12 citations

Percutaneous Coronary Intervention, Thrombosis, Chronic Response +12